Universal Technical Institute Inc (UTI) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Sep 30, 2026.

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free
Filings shown
41
Open-market buys
6
Open-market sells
15
Buys, 10b5-1 box not checked
6 of 6

Counts cover the 41 most recent Form 4 filings Tradune holds for UTI (filed Dec 12 – Sep 30, 2026); the score below covers only the trailing 90 days (6 buys, 0 sells). No completed check of UTI's Form 4 list on SEC EDGAR is on record yet; the latest UTI filing Tradune holds was filed Sep 30, 2026. This is not guaranteed to be the complete record — see UTI's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 6 filings Tradune holds for UTI filed Aug 12 – Sep 30, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Robert Thomas DevincenziDirector 6 0 13,000 — +$334,697

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score
56/ 100
Net insider purchases
1 distinct buyer6 buy · 0 sell txofficer buying

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at UTI

Insiders reported 6 open-market purchases of UTI between Dec 12, 2025 and Sep 30, 2026, across 1 distinct buyer. The most recent purchase was reported by Robert Thomas Devincenzi (Director) on Sep 28, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Robert Thomas Devincenzi Director · filed Sep 30, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 1,000 $19.68 153,330 +0.7% Sep 28, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Robert Thomas Devincenzi Director · filed Sep 23, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 1,000 $19.83 152,330 +0.7% Sep 21, 2026
Robert Thomas Devincenzi Director · filed Aug 31, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 1,000 $21.80 151,330 +0.7% Aug 27, 2026
Robert Thomas Devincenzi Director · filed Aug 27, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 1,000 $21.77 150,330 +0.7% Aug 25, 2026
Robert Thomas Devincenzi Director · filed Aug 14, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 1,000 $25.95 149,330 +0.7% Aug 12, 2026
Robert Thomas Devincenzi Director · filed Aug 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 8,000 $28.21 148,330 +5.7% Aug 10, 2026
Jerome Alan Grant Chief Executive Officer · filed Jun 30, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 48,961 $41.63 335,715 −13% Jun 29, 2026
Open-market sale 10b5-1 box not checked 45,539 $41.15 384,676 −11% Jun 29, 2026
Kevin Prehn Concorde Division President · filed Jun 24, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 4,545 $40.00 27,025 −14% Jun 22, 2026
Coliseum Capital Management, LLC Director · filed Jun 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 3,000,000 $41.40 971,440 (indirect) −76% Jun 8, 2026
Christine Kline Senior Vice President and CAO · filed Jun 8, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 3,500 $44.42 43,006 −7.5% Jun 5, 2026
William J. Lennox Jr. Director · filed Jun 8, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Gift 4,600 — 118,568 −3.7% Jun 5, 2026
Tracy Kay Lorenz SVP and UTI Division President · filed May 27, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 3,353 $40.06 65,445 −4.9% May 27, 2026
Tax withholding 18,720 $40.06 68,798 −21% May 27, 2026
Grant / award 42,243 — 87,518 +93% May 25, 2026
Linda J. Srere Director · filed May 13, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 15,000 $36.59 127,564 −11% May 11, 2026
Christopher E. Kevane EVP and Chief Legal Officer · filed Mar 31, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 23,654 $37.55 83,521 −22% Mar 27, 2026
George W. Brochick Director · filed Mar 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 5,000 $36.59 27,516 (indirect) −15% Mar 17, 2026
Shannon Lei Okinaka Director · filed Mar 9, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 10,000 $34.74 19,808 −34% Mar 6, 2026
Shannon Lei Okinaka Director · filed Mar 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 3,565 — 29,808 +14% Mar 5, 2026
Michael A. Slubowski Director · filed Mar 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 3,565 — 20,675 +21% Mar 5, 2026
George W. Brochick Director · filed Mar 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 3,565 — 4,279 +499% Mar 5, 2026
Linda J. Srere Director · filed Mar 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 3,565 — 142,564 +2.6% Mar 5, 2026
Loretta Lydia Sanchez Director · filed Mar 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 3,565 — 21,590 +20% Mar 5, 2026
Robert Thomas Devincenzi Director · filed Mar 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 3,565 — 140,330 +2.6% Mar 5, 2026
William J. Lennox Jr. Director · filed Mar 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 3,565 — 123,168 +3.0% Mar 5, 2026
Kenneth R. Trammell Director · filed Mar 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 3,565 — 136,083 +2.7% Mar 5, 2026
Todd A. Hitchcock EVP/COO · filed Mar 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 16,500 $37.33 104,084 −14% Mar 4, 2026

Listing the 25 most recent of 41 Form 4 filings held for UTI; the 16 older filings (filed Dec 12 – Mar 6, 2026) are counted above but not listed here — see UTI's full Form 4 filing history on SEC EDGAR.

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to UTI's (Sep 30, 2026).

Frequently asked about UTI insider activity

How many insiders bought UTI stock in these Form 4 filings?

1 distinct insider at Universal Technical Institute Inc reported 6 open-market purchases (Form 4 code P) of UTI shares between Dec 12, 2025 and Sep 30, 2026, the most recent filed by Robert Thomas Devincenzi (Director) on Sep 28, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for UTI?

The most recent Form 4 on this page was filed by Robert Thomas Devincenzi (Director) on Sep 30, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market UTI insider sale shown?

The largest open-market sale among the filings shown was 3,000,000 UTI shares at $41.40 (about $124,200,000) by Coliseum Capital Management, LLC (Director) on Jun 8, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

Do the recent UTI insider purchases have the Form 4 10b5-1 box checked?

No. All 6 UTI open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Robert Thomas Devincenzi (Director) on Sep 28, 2026, 1,000 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for UTI — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

Track UTI insider filings free →

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.